FDA 510(k) FDA class 1 Substantially Equivalent 🇺🇸 United States

EPSTEIN-BARR VIRUS EARLY ANTIGEN (EBV-EA) IGG IFA TEST SYSTEM

K Number: K992587 · Decision Dec 22, 1999
Classifications
1
FEI Numbers
15
Registration Numbers
15
Same Product Code
55
Applicant Total
7
Review Days
142

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
EPSTEIN-BARR VIRUS EARLY ANTIGEN (EBV-EA) IGG IFA TEST SYSTEM
K Number
K992587
Device Class
FDA class 1
Clearance Type
Traditional
Regulation Number
866.3235
Medical Specialty
Microbiology
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
Stellar Bio Systems, Inc.
Date Received
August 2, 1999
Decision Date
December 22, 1999
Product Code
LSE
Advisory Committee
Microbiology
Review Advisory Committee
MI
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
LSE Epstein-Barr Virus, Other

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (LSE), ordered by most recent decision date.

View all

Other Clearances by Stellar Bio Systems, Inc.

K Number Device Name
K990916 INDIRECT FLUORESCENCE ASSAY FOR ANTI-NATIVE DNA IGG ANTIBODY
K990915 INDIRECT FLUORESCENCE ASSAY FOR ANTI-NUCLEAR ANTIBODIES IGG ANTIBODY
K914953 IFA FOR CHLAMYDIA TRACHOMATIS IGG ANTIBODY
K905608 INDIRECT FLUORESCENT ASSAY FOR HERPES SIMPLEX 1
K900974 INDIRECT FLUORESCENT ASSAY FOR (EBV-VCA) IGG ANTI.
K882835 INDIRECT FLUORESCENT ASSAY FOR (HCMV)